These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 19752858)
1. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Byon CH; Hardy RW; Ren C; Ponnazhagan S; Welch DR; McDonald JM; Chen Y Lab Invest; 2009 Nov; 89(11):1221-8. PubMed ID: 19752858 [TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells. Shin S; Kim MK; Jung W; Chong Y Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577 [TBL] [Abstract][Full Text] [Related]
3. PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Fabre-Guillevin E; Malo M; Cartier-Michaud A; Peinado H; Moreno-Bueno G; Vallée B; Lawrence DA; Palacios J; Cano A; Barlovatz-Meimon G; Charrière-Bertrand C Breast Cancer Res; 2008; 10(6):R100. PubMed ID: 19055748 [TBL] [Abstract][Full Text] [Related]
4. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
5. Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis. Fortenberry YM; Brandal SM; Carpentier G; Hemani M; Pathak AP PLoS One; 2016; 11(10):e0164288. PubMed ID: 27755560 [TBL] [Abstract][Full Text] [Related]
6. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine. Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697 [TBL] [Abstract][Full Text] [Related]
7. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range. Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry AR Biochimie; 2007 Oct; 89(10):1228-33. PubMed ID: 17509745 [TBL] [Abstract][Full Text] [Related]
9. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1. Whitley BR; Church FC Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925 [TBL] [Abstract][Full Text] [Related]
10. Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. Chen C; Sun MZ; Liu S; Yeh D; Yu L; Song Y; Gong L; Hao L; Hu J; Shao S BMB Rep; 2010 Aug; 43(8):554-60. PubMed ID: 20797318 [TBL] [Abstract][Full Text] [Related]
11. Migration and invasion induced by linoleic acid are mediated through fascin in MDA-MB-231 breast cancer cells. Gonzalez-Reyes C; Marcial-Medina C; Cervantes-Anaya N; Cortes-Reynosa P; Salazar EP Mol Cell Biochem; 2018 Jun; 443(1-2):1-10. PubMed ID: 29052029 [TBL] [Abstract][Full Text] [Related]
12. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Chen Y; Billadello JJ; Schneider DJ Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2696-701. PubMed ID: 11116074 [TBL] [Abstract][Full Text] [Related]
13. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells. Whitley BR; Palmieri D; Twerdi CD; Church FC Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846 [TBL] [Abstract][Full Text] [Related]
14. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related]
15. PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells. Fang H; Jin J; Huang D; Yang F; Guan X Cancer Sci; 2018 Jun; 109(6):1949-1957. PubMed ID: 29601121 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and Vinblastine Increase Plasminogen Activator Inhibitor-1 Production in Human Breast Cancer MCF-7 Cells but Not MDA-MB-231 Cells. Morimoto-Kamata R; Ohkura N Biol Pharm Bull; 2024; 47(9):1494-1503. PubMed ID: 39261049 [TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085 [TBL] [Abstract][Full Text] [Related]
18. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages. Kishore P; Li W; Tonelli J; Lee DE; Koppaka S; Zhang K; Lin Y; Kehlenbrink S; Scherer PE; Hawkins M Sci Transl Med; 2010 Feb; 2(20):20ra15. PubMed ID: 20371491 [TBL] [Abstract][Full Text] [Related]
19. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Bajou K; Lewalle JM; Martinez CR; Soria C; Lu H; Noël A; Foidart JM Int J Cancer; 2002 Aug; 100(5):501-6. PubMed ID: 12124797 [TBL] [Abstract][Full Text] [Related]
20. Changes in uPA, PAI-1, and TGF-β Production during Breast Cancer Cell Interaction with Human Mesenchymal Stroma/Stem-Like Cells (MSC). Melzer C; von der Ohe J; Otterbein H; Ungefroren H; Hass R Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]